Paul Bryson

Dr. Paul Bryson


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Voice
Verified
Journal Article
Closed access
AHAshleigh A. Halderman
Ashleigh A. Halderman
PBPaul Bryson
Paul Bryson
MBMichael S. Benninger
Michael S. Benninger
RCRebecca Chota
Rebecca Chota

16 June 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MBMichael S. Benninger
Michael S. Benninger
EZEmily S. Zhang
Emily S. Zhang
BCBonnie Chen
Bonnie Chen
WTWilliam S. Tierney
William S. Tierney
BABasem Abdelmalak
Basem Abdelmalak
PBPaul Bryson
Paul Bryson

10 April 2018 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
ABAndrew Jay Bowen
Andrew Jay Bowen
ANAmy S. Nowacki
Amy S. Nowacki
KCKevin Contrera
Kevin Contrera
DTDouglas Trask
Douglas Trask
JKJames Kaltenbach
James Kaltenbach
PBPaul Bryson
Paul Bryson

1 August 2019 in Otolaryngologic Clinics of North America
Verified
Journal Article
Closed access
SRSaranya Reghunathan
Saranya Reghunathan
PBPaul Bryson
Paul Bryson

26 September 2023 in The Laryngoscope
Verified
Journal Article
Open access
BQBrooke A. Quinton
Brooke A. Quinton
WTWilliam S. Tierney
William S. Tierney
MBMichael S. Benninger
Michael S. Benninger
RNRebecca C. Nelson
Rebecca C. Nelson
VGVictoria L. Gau
Victoria L. Gau
PBPaul Bryson
Paul Bryson
Objective(s): The aim was to investigate the utilization and efficacy of bilateral superior laryngeal nerve block in patients with refractory chronic cough.Methods: A retrospective chart review of 164 patients with refractory chronic cough who underwent bilateral SLN block at a single institution between November 2018 and September 2022 was performed. Demographics, comorbidities, and patient‐reported outcomes including pre‐ and postinjection Leicester Cough Questionnaire (LCQ) scores were collected and analyzed.Results: The cohort underwent an average of 2.97 bilateral injections (range 1–22), containing either corticosteroid and local anesthetic or corticosteroid alone. Notably, 116 of 164 of patients reported an average of 67.3% reduction in their symptoms, with the treatment effect lasting 7.60 weeks on average. The average pre‐ and postinjection LCQ scores were 9.70 and 13.82, respectively. A lower LCQ score represents a greater impairment of health status due to cough, and the minimum important change is 1.3 points between questionnaires. The average improvement on LCQ following bilateral SLN block was 4.11 points for this cohort.Conclusion: The use of in‐office bilateral SLN block is an effective treatment that can be used alone or in conjunction with oral medications for the treatment of refractory chronic cough.Level of Evidence: 4 Laryngoscope, 134:1773–1777, 2024

13 December 2023 in The Laryngoscope
Verified
Journal Article
Closed access
EEEmily Evangelista
Emily Evangelista
RKRohan Kale
Rohan Kale
DMDesiree McCutcheon
Desiree McCutcheon
ARAnaïs Rameau
Anaïs Rameau
AGAlexander Gelbard
Alexander Gelbard
YBYael Bensoussan
Yael Bensoussan